Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Income Tax Expense
The tax expense for Labcorp Holdings Inc. (LH) is $229.80 Million with a year-over-year change of +8.19%. Income tax expense is the amount a company pays in federal, state, and foreign income taxes based on its taxable income for the period.
LH Tax Expense Chart
LH Tax Expense
$229.80M-9.71% 20Y
Zoom
Current Tax Expense
$229.80M
$229.80 Million
Year-over-Year Change
+8.19%
vs. $212.40M prior year
Historical Data
30
Years of data available
Annual Tax Expense History
| Year | Tax Expense | YoY Change | % Change |
|---|---|---|---|
| 2025 | $229.80M | +$17.40M | +8.19% |
| 2024 | $212.40M | +$23.90M | +12.68% |
| 2023 | $188.50M | $-45.40M | -19.41% |
| 2022 | $233.90M | $-456.10M | -66.10% |
| 2021 | $690.00M | +$27.90M | +4.21% |
| 2020 | $662.10M | +$382.10M | +136.46% |
| 2019 | $280.00M | $-104.40M | -27.16% |
| 2018 | $384.40M | +$523.50M | +376.35% |
| 2017 | $-139.10M | $-511.40M | -137.36% |
| 2016 | $372.30M | +$78.20M | +26.59% |
| 2015 | $294.10M | $-20.00M | -6.37% |
| 2014 | $314.10M | $-26.10M | -7.67% |
| 2013 | $340.20M | $-19.20M | -5.34% |
| 2012 | $359.40M | +$26.40M | +7.93% |
| 2011 | $333.00M | $-11.00M | -3.20% |
| 2010 | $344.00M | +$15.00M | +4.56% |
| 2009 | $329.00M | +$21.10M | +6.85% |
| 2008 | $307.90M | $-17.60M | -5.41% |
| 2007 | $325.50M | +$36.20M | +12.51% |
| 2006 | $289.30M | +$34.80M | +13.67% |
| 2005 | $254.50M | +$2.20M | +0.87% |
| 2004 | $252.30M | +$32.90M | +15.00% |
| 2003 | $219.40M | +$41.70M | +23.47% |
| 2002 | $177.70M | +$28.10M | +18.78% |
| 2001 | $149.60M | +$54.10M | +56.65% |
| 2000 | $95.50M | +$55.40M | +138.15% |
| 1999 | $40.10M | +$27.40M | +215.75% |
| 1998 | $12.70M | +$67.10M | +123.35% |
| 1997 | $-54.40M | $-19.60M | -56.32% |
| 1996 | $-34.80M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter